| scholarly article | Q13442814 |
| P2093 | author name string | Tomonori Nakamura | |
| Masahiko Kurabayashi | |||
| Yoshihisa Nojima | |||
| Katsunori Nakamura | |||
| Koujirou Yamamoto | |||
| Takuya Araki | |||
| Kyoko Obayashi | |||
| Katsuyuki Hara | |||
| P2860 | cites work | Meta-analysis of the impact of 9 medication classes on falls in elderly persons | Q37637615 |
| Benzodiazepines of long and short elimination half-life and the risk of hip fracture | Q38367453 | ||
| Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are different | Q39923376 | ||
| Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes. | Q40417870 | ||
| Central nervous system-active medications and risk for falls in older women | Q40628780 | ||
| Recent developments in the behavioral pharmacology of benzodiazepine (omega) receptors: evidence for the functional significance of receptor subtypes | Q40645721 | ||
| Falls in the nursing home | Q40684671 | ||
| Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein | Q40685094 | ||
| Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. | Q40827242 | ||
| Epidemiology of medication-related falls and fractures in the elderly. | Q41702956 | ||
| Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam | Q42111101 | ||
| Inhibition of the metabolism of brotizolam by erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in brotizolam metabolism | Q42155588 | ||
| Pharmacological profile and clinical effect of zolpidem (Myslee tablets), a hypnotic agent | Q43894208 | ||
| Effects of the CYP2C19 genotype and cigarette smoking on the single oral dose pharmacokinetics and pharmacodynamics of estazolam | Q44400992 | ||
| Relationship between the risk of falling and drugs in an academic hospital | Q45764293 | ||
| Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone | Q46453447 | ||
| Comparison of typical and atypical benzodiazepines on the central and peripheral benzodiazepine receptors. | Q48295765 | ||
| Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study | Q48572669 | ||
| Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human [...] | Q24316082 | ||
| International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update | Q24608968 | ||
| Concentrations and effects of zopiclone are greatly reduced by rifampicin | Q24673505 | ||
| Pharmacological profiles of benzodiazepinergic hypnotics and correlations with receptor subtypes | Q28263703 | ||
| Kinetic and pharmacological studies on estazolam in mice and man | Q28282096 | ||
| Interaction between grapefruit juice and hypnotic drugs: comparison of triazolam and quazepam | Q28292107 | ||
| Type I and type II GABAA-benzodiazepine receptors produced in transfected cells | Q28342945 | ||
| Falls risk factors in the hospital setting: a systematic review | Q30800634 | ||
| Drug-induced orthostatic hypotension in the elderly: avoiding its onset | Q33175327 | ||
| The safety and tolerability of zolpidem--an update | Q33604198 | ||
| Medication use as a risk factor for inpatient falls in an acute care hospital: a case-crossover study | Q33795088 | ||
| Gamma-aminobutyric acidA receptor alpha 5-subunit creates novel type II benzodiazepine receptor pharmacology. | Q33902225 | ||
| Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia | Q33914366 | ||
| Treatment options for insomnia. | Q34006902 | ||
| Binding and neuropharmacological profile of zaleplon, a novel nonbenzodiazepine sedative/hypnotic | Q34106461 | ||
| A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia. | Q34332784 | ||
| Obesity effects on nitrazepam disposition | Q34448167 | ||
| An update on falls | Q35052279 | ||
| Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men. | Q35825681 | ||
| Effect of voriconazole on the pharmacokinetics and pharmacodynamics of zolpidem in healthy subjects | Q36024937 | ||
| Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. | Q36678681 | ||
| Use of selective serotonin-reuptake inhibitors or tricyclic antidepressants and risk of hip fractures in elderly people. | Q50879873 | ||
| The use of sedative/hypnotic medication and its correlation with falling down in the hospital. | Q50959455 | ||
| Predictors for recurrent falls among the home-dwelling elderly. | Q51024912 | ||
| Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences. | Q51081429 | ||
| Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. | Q51434685 | ||
| Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo. | Q52036594 | ||
| Age, sex, and nitrazepam kinetics: relation to antipyrine disposition. | Q54269436 | ||
| The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone | Q60449866 | ||
| The clinical pharmacokinetics of single doses of estazolam | Q68084210 | ||
| Oxidative metabolism of zolpidem by human liver cytochrome P450S | Q70978034 | ||
| Incidence of falls in three different types of geriatric care. A Swedish prospective study | Q73232542 | ||
| Relationship between single oral dose pharmacokinetics of alprazolam and triazolam | Q73567978 | ||
| Pharmacodynamics and pharmacokinetics of a single oral dose of nitrazepam in healthy volunteers: an interethnic comparative study between Japanese and European volunteers | Q73746980 | ||
| Antidepressants and the risk of falls among nursing home residents | Q77323596 | ||
| Medication use and risk of falls | Q78073512 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 2.5 Generic | Q19113746 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 159-164 | |
| P577 | publication date | 2013-06-01 | |
| P1433 | published in | Drugs in R & D | Q26842117 |
| P1476 | title | Risk of falling and hypnotic drugs: retrospective study of inpatients | |
| P478 | volume | 13 |
| Q47680110 | Eight-Year Follow-up of Hypnotic Delivery by Adults Aged 50 and Older from an Insurance Database |
| Q28548098 | Hypnotics and the Occurrence of Bone Fractures in Hospitalized Dementia Patients: A Matched Case-Control Study Using a National Inpatient Database |
| Q44227609 | Hyponatremia and hypokalemia as risk factors for falls. |
| Q57821978 | Mild cognitive impairment: associations with sleep disturbance, apolipoprotein e4, and sleep medications |
| Q38217284 | New and emerging pharmacotherapeutic approaches for insomnia |
| Q88141621 | Safety of brotizolam in hospitalized patients |
| Q36432716 | Sleeping Pill Administration Time and Patient Subjective Satisfaction |
| Q55419661 | South Korean geriatrics on Beers Criteria medications at risk of adverse drug events. |
Search more.